Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1061 | 1061 | 1073 | 1084 | 1418 | 2002 |
Fund Return | 6.08% | 6.08% | 7.27% | 2.73% | 7.23% | 7.19% |
Place in category | 311 | 311 | 191 | 312 | 93 | 31 |
% in Category | 46 | 46 | 33 | 56 | 21 | 11 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Pictet CH Institutional Swiss EquZD | 1.54B | 3.74 | 2.02 | 7.33 | ||
Pictet CH Institutional Swiss EquiP | 1.54B | 6.02 | 2.53 | 6.98 | ||
Pictet CH Institutional Swiss EquiZ | 1.48B | 2.66 | 4.28 | 7.37 | ||
Pictet CH Institutional Swiss EquID | 1.48B | 2.58 | 3.78 | 6.87 | ||
Pictet CH Institutional Swiss EquPD | 1.48B | 2.54 | 3.57 | 6.65 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0033782431 | 2.47B | 3.85 | 3.74 | 6.24 | ||
Raiffeisen Futura Swiss Stock A | 2.07B | 2.12 | 2.41 | 6.12 | ||
UBS CH Equity Fund Swiss Income CHQ | 1.89B | 2.59 | 4.20 | 6.41 | ||
UBS CH Equity Fund Swiss Income CHF | 1.89B | 2.43 | 3.56 | 5.81 | ||
UBAM Swiss Equity AD CHF Inc | 1.8B | 7.99 | -0.55 | 5.90 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Nestle | CH0038863350 | 15.01 | 95.42 | -0.13% | |
Roche Holding Participation | CH0012032048 | 11.15 | 234.80 | +3.21% | |
Novartis | CH0012005267 | 9.78 | 92.62 | -0.73% | |
ABB | CH0012221716 | 5.51 | 47.65 | -1.14% | |
Zurich Insurance Group | CH0011075394 | 5.15 | 469.10 | +3.49% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review